Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence

Launched by COLUMBIA UNIVERSITY · Jun 24, 2020

Keywords

ClinConnect Summary

This clinical trial is studying how long the COVID-19 virus can stay in the body after someone has recovered and how quickly the body produces antibodies to fight the virus. Researchers want to find out how long a person might still be able to spread the virus and if there are any lingering health issues after recovering. To do this, they will enroll 300 people who have had COVID-19, confirmed either by lab tests or by their symptoms, and 25 people who have never had COVID-19 or the vaccine to serve as a comparison group.

Participants must be at least 7 years old and able to provide different types of samples, like blood and saliva, up to 12 times over two years. They will also fill out surveys about their health. By gathering this information, the researchers aim to help doctors and health officials provide better care and advice for people recovering from COVID-19. If you or someone you know might be interested in participating, please check if you meet the eligibility criteria!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Laboratory confirmed SARS-CoV-2 using currently available laboratory testing techniques (e.g.,RT-PCR, Immunoglobulin M (IgM) /IgG) or clinical history compatible with a COVID-19 like illness(fever, cough, shortness of breath).
• • Negative participants with no known prior COVID-19 diagnosis or COVID vaccine
• • At least 7 years of age
• • Participants are eligible to provide semen and breast milk samples if they are 18 years of age or older
• Exclusion Criteria:
• • Age \<7
• • Intercurrent conditions that in the opinion of the investigator would confound the findings of the study.